|
ISSN 1977-091X |
||
|
Official Journal of the European Union |
C 29 |
|
|
||
|
English edition |
Information and Notices |
Volume 64 |
|
Contents |
page |
|
|
|
II Information |
|
|
|
INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
|
European Commission |
|
|
2021/C 29/01 |
Non-opposition to a notified concentration (Case M.10066 — Carlyle/Flender) ( 1 ) |
|
|
IV Notices |
|
|
|
NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
|
European Commission |
|
|
2021/C 29/02 |
||
|
|
NOTICES FROM MEMBER STATES |
|
|
2021/C 29/03 |
|
|
V Announcements |
|
|
|
PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
|
|
|
European Commission |
|
|
2021/C 29/04 |
Prior notification of a concentration (Case M.10004 - EQT/Zentricity/Cajelo/Recipharm) – Candidate case for simplified procedure ( 1 ) |
|
|
2021/C 29/05 |
Prior notification of a concentration (Case M.10049 — Partners Group/Atlantia/Telepass) – Candidate case for simplified procedure ( 1 ) |
|
|
|
|
|
(1) Text with EEA relevance. |
|
EN |
|
II Information
INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES
European Commission
|
26.1.2021 |
EN |
Official Journal of the European Union |
C 29/1 |
Non-opposition to a notified concentration
(Case M.10066 — Carlyle/Flender)
(Text with EEA relevance)
(2021/C 29/01)
On 19 January 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:
|
— |
in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
|
— |
in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10066. EUR-Lex is the online access to European law. |
IV Notices
NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES
European Commission
|
26.1.2021 |
EN |
Official Journal of the European Union |
C 29/2 |
Euro exchange rates (1)
25 January 2021
(2021/C 29/02)
1 euro =
|
|
Currency |
Exchange rate |
|
USD |
US dollar |
1,2152 |
|
JPY |
Japanese yen |
126,06 |
|
DKK |
Danish krone |
7,4406 |
|
GBP |
Pound sterling |
0,88800 |
|
SEK |
Swedish krona |
10,0625 |
|
CHF |
Swiss franc |
1,0772 |
|
ISK |
Iceland króna |
157,00 |
|
NOK |
Norwegian krone |
10,3478 |
|
BGN |
Bulgarian lev |
1,9558 |
|
CZK |
Czech koruna |
26,080 |
|
HUF |
Hungarian forint |
357,33 |
|
PLN |
Polish zloty |
4,5409 |
|
RON |
Romanian leu |
4,8744 |
|
TRY |
Turkish lira |
8,9865 |
|
AUD |
Australian dollar |
1,5728 |
|
CAD |
Canadian dollar |
1,5459 |
|
HKD |
Hong Kong dollar |
9,4199 |
|
NZD |
New Zealand dollar |
1,6854 |
|
SGD |
Singapore dollar |
1,6124 |
|
KRW |
South Korean won |
1 340,18 |
|
ZAR |
South African rand |
18,4930 |
|
CNY |
Chinese yuan renminbi |
7,8712 |
|
HRK |
Croatian kuna |
7,5665 |
|
IDR |
Indonesian rupiah |
17 108,31 |
|
MYR |
Malaysian ringgit |
4,9149 |
|
PHP |
Philippine peso |
58,427 |
|
RUB |
Russian rouble |
91,6732 |
|
THB |
Thai baht |
36,438 |
|
BRL |
Brazilian real |
6,6434 |
|
MXN |
Mexican peso |
24,2927 |
|
INR |
Indian rupee |
88,6300 |
(1) Source: reference exchange rate published by the ECB.
NOTICES FROM MEMBER STATES
|
26.1.2021 |
EN |
Official Journal of the European Union |
C 29/3 |
Winding-up proceedings
Winding-up proceedings in respect of Nederlandsche Algemene Maatschappij van Levensverzekering ‘Conservatrix’ N.V. (the ‘Company’)
(Publication made in accordance with Article 280 of Directive 2009/138/EC of the European Parliament and of the Council on the taking up and pursuit of the business of Insurance and Reinsurance (Solvency II))
(2021/C 29/03)
|
Insurance undertaking |
Nederlandsche Algemene Maatschappij van Levensverzekering ‘Conservatrix’ N.V. |
|
Date, entry into force and nature of decision |
8 December 2020 |
|
Competent authorities |
Court of Amsterdam, delegated judges mr. M. de Vries and mr. A.E. de Vos |
|
Supervisory authority |
Court of Amsterdam, delegated judges mr. M. de Vries and mr. A.E. de Vos |
|
Trustees appointed |
mr. drs. W.J.M. van Andel and mr. E.L. Zetteler |
|
Applicable law |
Dutch Law |
V Announcements
PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY
European Commission
|
26.1.2021 |
EN |
Official Journal of the European Union |
C 29/4 |
Prior notification of a concentration
(Case M.10004 - EQT/Zentricity/Cajelo/Recipharm)
Candidate case for simplified procedure
(Text with EEA relevance)
(2021/C 29/04)
1.
On 18 January 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).This notification concerns the following undertakings:
|
— |
EQT IX Collect EUR SCSp and EQT IX Collect USD SCSp (together ‘EQT IX’), part of the EQT group of private equity funds (‘EQT’, Luxembourg); |
|
— |
Zentricity Holding AB (‘Zentricity’, Sweden); |
|
— |
Cajelo Invest Ltd (‘Cajelo’, Cyprus); and |
|
— |
Recipharm AB (‘Recipharm’, Sweden). |
EQT, Zentricity and Cajelo acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of Recipharm.
The concentration is accomplished by way of public bid announced on 14 December 2020.
2.
The business activities of the undertakings concerned are:|
— |
for EQT: private equity funds that invest in companies across the world, which amongst others control EQT IX, an investment fund investing primarily in Europe, with a focus on Northern Europe; |
|
— |
for Zentricity: investment company focusing on investing in pharmaceutical companies primarily in Sweden, which is controlled by private individual Thomas Eldered, who also controls the pharmaceutical companies Empros Pharma AB, Flerie Creations Ltd. and Flerie Invest AB; |
|
— |
for Cajelo: investment company which is controlled by private individual Lars Backsell, who also controls Glims Marketing Ltd. and Rohirrim AB, a horse breeding company. |
|
— |
for Recipharm: contract development and manufacturing organization, providing drug development and manufacturing services globally to the pharmaceutical industry (e.g. for finished dose pharmaceuticals, active pharmaceutical ingredients and clinical trial materials for customers in the pharmaceutical industry), as well as packaging services and logistics services. |
3.
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.
4.
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.10004 – EQT/Zentricity/Cajelo/Recipharm
Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu
Fax +32 22964301
Postal address:
|
European Commission |
|
Directorate-General for Competition |
|
Merger Registry |
|
1049 Bruxelles/Brussel |
|
BELGIQUE/BELGIË |
(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
|
26.1.2021 |
EN |
Official Journal of the European Union |
C 29/6 |
Prior notification of a concentration
(Case M.10049 — Partners Group/Atlantia/Telepass)
Candidate case for simplified procedure
(Text with EEA relevance)
(2021/C 29/05)
1.
On 18 January 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).This notification concerns the following undertakings:
|
— |
Partners Group AG (together with its affiliates, ‘Partners Group’, Switzerland), |
|
— |
Atlantia SpA (‘Atlantia’, Italy), |
|
— |
Telepass SpA (‘Telepass’, Italy), currently solely controlled by Atlantia (Italy) |
Partners Group and Atlantia acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Telepass.
The concentration is accomplished by way of purchase of shares.
2.
The business activities of the undertakings concerned are:|
— |
for Partners Group: global private investment management company active in the areas of private equity, private real estate, private infrastructure and private debt; |
|
— |
for Atlantia: holding company active mainly in the toll motorway and airport infrastructure sectors in Italy, Spain, France and, to a limited extent, Poland; |
|
— |
for Telepass: active mainly in the provision of electronic tolling services in Europe and, in particular, in Italy. |
3.
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.
4.
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.10049 — Partners Group/Atlantia/Telepass
Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu
Fax +32 22964301
Postal address:
|
European Commission |
|
Directorate-General for Competition |
|
Merger Registry |
|
1049 Bruxelles/Brussel |
|
BELGIQUE/BELGIË |
(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).